Recent News
Assessment of Histologic Prognostic Factors in Peritoneal Malignant Mesothelioma
Primary Outcome Measures Assessment of pronostic impact of nuclear grade in comparison with combined grade in peritoneal malignant mesothelioma [ Time Frame: 3 months to 4 years ] Assessment by the review of pathologists…
LMB-100 and Ipilumab Combination Being Tested for Pleural and Peritoneal Mesothelioma
The National Cancer Institute just started a study to see if it could make immunotherapy more potent for treating mesothelioma. The study combines a manmade protein that kills cancer cells…
GPX-1 Could be used as a Biomarker for Mesothelioma
An enzyme that helps clean up the byproducts of cellular oxidation could potentially be a biomarker for pleural mesothelioma. People with very small amounts of the enzyme were found to…
UCARTMESO CAR-T Cell Therapy Can Help Kill Mesothelioma Cells
A new treatment utilizing CAR-T cell therapy could help prevent mesothelioma cells from protecting themselves. The treatment, called UCARTMESO, is being developed by the French biopharmaceutical company Cellectis. The treatment…
Durvalumab and Chemotherapy Extends Mesothelioma Patients’ Lives
Studies are showing that the immunotherapy drug durvalumab can make chemotherapy more effective for treating mesothelioma. Durvalumab is an immunotherapy drug called an immune checkpoint inhibitor. It blocks the protein…
A Mesothelioma Blood Test Could Improve Patient Quality of Life
A blood test for mesothelioma could help increase the time between CT scan appointments. The typical way doctors test to see if a treatment is working is called mRECIST, which…
Follow Up Care for Mesothelioma
Follow-up care is crucial for treating mesothelioma patients. A study out of the United Kingdom found that when patients receive follow-up care, more input from their caregivers, continuity, and more…
SQAP Used Alongside Radiation to Treat Mesothelioma
A chemical that makes cancer cells more sensitive to radiation could potentially help patients with mesothelioma. Radiotherapy utilizes ionizing radiation to damage the DNA of cancer cells, which affects their…
Researchers Could Target Neuron Cells to Fight Mesothelioma
Researchers have potentially found a new way to treat cancer by targeting nerve cells. Researchers at Technion, the Israel Institute of Technology, conducted the study that is now published in…
Quinacrine Combined with Cisplatin Can Help Fight Mesothelioma Cancer Cells
Mesothelioma patients with a gene mutation could benefit greatly from using an anti-malaria drug called quinacrine. Quinacrine is known by the brand name Atabrine. For a long time, it was…
